1. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. Issue 10 (October 2017) Authors: Yazici, Y.; McAlindon, T.E.; Fleischmann, R.; Gibofsky, A.; Lane, N.E.; Kivitz, A.J.; Skrepnik, N.; Armas, E.; Swearingen, C.J.; DiFrancesco, A.; Tambiah, J.R.S.; Hood, J.; Hochberg, M.C. Journal: Osteoarthritis and cartilage Issue: Volume 25:Issue 10(2017) Page Start: 1598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Issue 5 (May 2021) Authors: Yazici, Y.; McAlindon, T.E.; Gibofsky, A.; Lane, N.E.; Lattermann, C.; Skrepnik, N.; Swearingen, C.J.; Simsek, I.; Ghandehari, H.; DiFrancesco, A.; Gibbs, J.; Tambiah, J.R.S.; Hochberg, M.C. Journal: Osteoarthritis and cartilage Issue: Volume 29:Issue 5(2021) Page Start: 654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0286 A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-To-Target Approach in the Clinical Care of Rheumatoid Arthritis Patients. (9th June 2015) Authors: Harrold, L.R.; Reed, G.W.; Harrington, J.T.; Barr, C.J.; Saunders, K.C.; Gibofsky, A.; Greenberg, J.D.; John, A.; Devenport, J.; Kremer, J.M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0416 Estimating the short-term costs associated with non-medical switching in rheumatic diseases. (12th June 2018) Authors: Gibofsky, A.; Garg, V.; Yang, M.; Qi, C.Z.; Skup, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0460 Long-term drug survival of etanercept vs other tnf inhibitor therapies in patients with rheumatoid arthritis. (12th June 2018) Authors: Emery, P.; Vlahos, B.; Szczypa, P.; Thakur, M.; Jones, H.E.; Woolcott, J.; Santos Estrella, P.V.; Gibofsky, A.; Rolland, C.; Citera, G.; Marshall, L. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee. (April 2019) Authors: Yazici, Y.; McAlindon, T.E.; Gibofsky, A.; Lane, N.E.; Latterman, C.; Skrepnik, N.; Swearingen, C.J.; DiFrancesco, A.; Tambiah, J.R.; Hochberg, M.C. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0052 Variations in Disease Activity and Therapeutic Management of Rheumatoid Arthritis in Different International Regions: A Comparison of Data from the Corrona International and Corrona US Registries. (10th June 2014) Authors: Pappas, D.A.; Lampl, K.; Kremer, J.M.; Radominski, S.C.; Gal, J.; Nyberg, F.; Malaviya, A.; Whitworth, A.; Rillo, O.; Gibofsky, A.; Popkova, T.; Ho, M.; Laurindo, I.; Reed, G.W.; Kerzberg, E.M.; Horne, L.; Zahora, R.; Saunders, K.C.; Pons-Estel, B.A.; Onofrei, A.U. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0534 Radiographic outcomes were associated with pain and function responses: post-hoc analysis from a phase 2 study of a wnt pathway inhibitor, sm04690, for knee osteoarthritis treatment. (12th June 2018) Authors: Swearingen, C.; Tambiah, J.; Gibofsky, A.; Lane, N.; McAlindon, T.; Hochberg, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Low-dose solumatrix meloxicam demonstrates low systemic exposure and efficacy in patients with osteoarthitis pain in clinical studies. (April 2015) Authors: Altman, R.; Hochberg, M.; Gibofsky, A.; Kwong, L.; Young, C. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Low-dose SoluMatrix meloxicam results in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis. (April 2016) Authors: Altman, R.; Hochberg, M.; Kivitz, A.; Gibofsky, A.; Solorio, D.; Young, C. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗